BSE:EPBIO
EP Biocomposites Ltd · BSE · Industrials · INR · FY for 2026
Figures on this page computed 2026-11-08 13:04 UTC
Last close
n/aINR
Market data
10.1xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
- Computed from the filing for 2026
13.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
10.7%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
10.3%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.20Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth35.9%62 of 100, above its sector
- Returns on capital13.1%77 of 100, above its sector
- Margins36.6%67 of 100, above its sector
- Price10.1x75 of 100, above its sector
- Safety0.2067 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales1.63x
Its own average over 7 years, 83.8M.
- Profit1.63x
Its own average over 6 years, 9.0M.
- Free cash flow-1.81x
Its own average over 7 years, -7.7M.
- Debt1.14x
Its own average over 6 years, 21.0M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at -1.81 times.
Sales is 1.63 times its own 7-year average; Profit is 1.63 times its own 6-year average; Free cash flow is -1.81 times its own 7-year average; Debt is 1.14 times its own 6-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2026
Sales against its own 7-year average1.63
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Profit against its own 6-year average1.63
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Free cash flow against its own 7-year average-1.81
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Debt against its own 6-year average1.14
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- INR